NEW ONSET DIABETES AFTER TRANSPLANTATION

This adverse event was reported 173 times

NEW ONSET DIABETES AFTER TRANSPLANTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTI-THYMOCYTE GLOBULIN (RABBIT) 18 0.0022
1 BELATACEPT 9 0.0019
2 MYCOPHENOLIC ACID 52 0.0016
3 VALGANCICLOVIR 24 0.0013
4 TACROLIMUS OINTMENT 0.1% 155 0.0012
5 TACROLIMUS EXTENDED-RELEASE CAPSULES 155 0.0012
6 TACROLIMUS 168 0.0011
7 DARUNAVIR 600 MG 6 0.0010
8 BASILIXIMAB 11 0.0009
9 CIDOFOVIR ANHYDROUS 1 0.0007
See all drugs enriched for association with NEW ONSET DIABETES AFTER TRANSPLANTATION